Skip to main content

Articles

Page 39 of 76

  1. Ovarian serous cystadenocarcinoma (OSC) is the most common and lethal gynecological cancer in women worldwide; however, biomarkers to diagnose and predict prognosis of OSC remain limited. Therefore, the presen...

    Authors: Wei Huang, Yongjian Zhang, Ye Xu, Shaoyou Yang, Bing Li, Lan Huang and Ge Lou
    Citation: Cancer Cell International 2020 20:309
  2. Although the fact that long non-coding RNA MCM3AP antisense RNA 1 (MCM3AP-AS1) is oncogenic in several cancers is well documented, very few researchers investigate its expression and function in prostate cancer.

    Authors: Jie Wu, Yalin Lv, Yujun Li, Yanxia Jiang, Lili Wang, Xiangyan Zhang, Mengqi Sun, Yuwei Zou, Jin Xu and Li Zhang
    Citation: Cancer Cell International 2020 20:307
  3. Autophagy is associated with cancer development. Autophagy-related genes play significant roles in endometrial cancer (EC), a major gynecological malignancy worldwide, but little was known about their value as...

    Authors: Hui Wang, Xiaoling Ma, Jinhui Liu, Yicong Wan, Yi Jiang, Yankai Xia and Wenjun Cheng
    Citation: Cancer Cell International 2020 20:306
  4. Osteosarcoma (OS) is the most common bone malignant tumor in children, youth, and adolescents. Circular RNA hsa_circ_0005909 (circ_0005909) is involved in the progression of OS. Nevertheless, there are few rep...

    Authors: Shuai Ding, Guangquan Zhang, Yanzheng Gao, Shulian Chen and Chen Cao
    Citation: Cancer Cell International 2020 20:305
  5. It has been widely reported that the expression levels of SNHG20 are elevated in diverse types of cancers, indicating that SNHG20 may participate in cancer initiation and development. Besides, accumulating evi...

    Authors: Hanlong Zhu, Si Zhao, Ruonan Jiao, Huishan Wang, Ruiyi Tang, Xiaochao Wu, Fei Wang, Xianxiu Ge, Quanpeng Li and Lin Miao
    Citation: Cancer Cell International 2020 20:304
  6. Gastric cancer (GC) is the leading cause of death worldwide and is closely related to metastasis. MRTF-A is one of the most well-characterized genetic markers in cancer. However, the mechanism whereby MRTF-A m...

    Authors: Libin Yin, Tao Liu, Chenyao Li, Guoqiang Yan, Chao Li, Jiantao Zhang and Lei Wang
    Citation: Cancer Cell International 2020 20:303
  7. Bladder cancer (BCa) is one of the important tumors that have been proven to be treatable with immunotherapy. This study aims to identify and validate a molecular prognostic index of BCa based on immunogenomic...

    Authors: Ning Xu, Zhi-Bin Ke, Xiao-Dan Lin, Ye-Hui Chen, Yu-Peng Wu, Yu Chen, Ru-Nan Dong, Shao-Hao Chen, Xiao-Dong Li, Yong Wei, Qing-Shui Zheng, Yun-Zhi Lin and Xue-Yi Xue
    Citation: Cancer Cell International 2020 20:302
  8. Researches validate that circular RNAs (circRNAs) are dysregulated in a variety of malignancies and play an important role in regulating the malignant phenotype of tumor cells. Nevertheless, the role of circ_0...

    Authors: Li Zhang, Jie Wu, Yujun Li, Yanxia Jiang, Lili Wang, Yunqing Chen, Yalin Lv, Yuwei Zou and Xiaoyan Ding
    Citation: Cancer Cell International 2020 20:301
  9. The mechanisms of neuronal protein γ-synuclein (SNCG) in the malignancy of oral squamous cell carcinoma (OSCC) are not clear. This study tested the hypothesis that SNCG is involved in nicotine-induced malignan...

    Authors: Chia-Chen Hsu, Yu-Fu Su, Kuo-Yang Tsai, Feng-Chih Kuo, Chi-Fu Chiang, Chu-Yen Chien, Ying-Chen Chen, Chien-Hsing Lee, Yu-Chiao Wu, Kun Wang, Shyun-Yeu Liu and Yi-Shing Shieh
    Citation: Cancer Cell International 2020 20:300

    The Correction to this article has been published in Cancer Cell International 2020 20:410

  10. Small nucleolar RNAs (snoRNAs) are a new non-coding RNAs (ncRNAs), which have not been widely investigated and are identified to be involved in tumorigenesis. But the function of snoRNAs in BLCA has not been r...

    Authors: Rui Cao, Bo Ma, Lushun Yuan, Gang Wang and Ye Tian
    Citation: Cancer Cell International 2020 20:299
  11. Cancer remains one of the major culprits causing disease-related deaths and leads to a high morbidity and similar mortality. Insidious onset, difficult early detection and a lack of broad-spectrum and effectiv...

    Authors: Yizhi Wang, Li Zhou, Jun Lu, Bolun Jiang, Chengxi Liu and Junchao Guo
    Citation: Cancer Cell International 2020 20:298
  12. Pancreatic ductal adenocarcinoma (PDAC), a subtype of pancreatic cancer, is a malignant tumor with unfavorable prognosis. Despite accumulating researches have made efforts on finding novel therapeutic methods ...

    Authors: Liping Wu, Yongcun Liu, Cheng Guo and Yuan Shao
    Citation: Cancer Cell International 2020 20:296
  13. Hepatocellular carcinoma (HCC) is a common malignant tumor in China. Advanced treatment like transcatheter hepatic arterial chemoembolization (TACE) has prolonged the lives of man...

    Authors: Xialei Liu, Lewei Yang, Dong Jiang, Wuzhu Lu and Yongyu Zhang
    Citation: Cancer Cell International 2020 20:295

    The Retraction Note to this article has been published in Cancer Cell International 2021 21:355

  14. Thyroid cancer (TC) is the most frequent endocrine malignancy. Long noncoding RNAs (lncRNAs) have been confirmed to act as significant roles in tumor development. The role of lncRNA TMPO-AS1 in TC is still unc...

    Authors: Zhenyu Li, Yun Feng, Zhen Zhang, Xiaozhong Cao and Xiubo Lu
    Citation: Cancer Cell International 2020 20:294
  15. In cervical cancer, most patients die of metastasis. The epithelial-to-mesenchymal transition (EMT) is a pivotal and intricate process that increases the metastatic potential of cervical cancer. C-phycocyanin ...

    Authors: Huanhuan Ji, Guoxiang Liu, Jingjing Han, Feng Zhu, Xiaolei Dong and Bing Li
    Citation: Cancer Cell International 2020 20:292
  16. Bladder cancer is having a gradually increasing incidence in China. Except for the traditional chemotherapy drugs, there are no emerging new drugs for almost 30 years in bladder cancer. New potential therapeut...

    Authors: Songtao Cheng, Tianchen Peng, Xiaolu Zhu, Fenfang Zhou, Gang Wang, Lingao Ju, Yu Xiao, Xuefeng Liu and Xinghuan Wang
    Citation: Cancer Cell International 2020 20:290
  17. Cisplatin (DDP) is the first-line chemotherapeutic drug for non-small cell lung cancer (NSCLC), and long-term DDP stimulation increased resistance of NSCLC cells to this drug by enriching cancer stem cells (CS...

    Authors: Yongsheng Zhao, Renyan Zheng, Jian Chen and Dong Ning
    Citation: Cancer Cell International 2020 20:289
  18. At the present time, colorectal cancer (CRC) is still known as a disease with a high mortality rate. Theranostics are flawless scenarios that link diagnosis with therapy, including precision medicine as a crit...

    Authors: Somayeh Vafaei, Raheleh Roudi, Zahra Madjd, Amir Reza Aref and Marzieh Ebrahimi
    Citation: Cancer Cell International 2020 20:288
  19. Although tremendous improvement has been seen in cancer diagnosis and treatment, its morbidity and mortality is still high due to lack of ideal biomarkers. An increasing number of studies have demonstrated tha...

    Authors: Haixiang Shen, Qiwang Mo, Xin Xu and Ben Liu
    Citation: Cancer Cell International 2020 20:286
  20. Survival outcomes are significantly different in stage II colorectal cancer (CRC) patients with diverse clinicopathological features. The objective of this study is to establish a credible prognostic nomogram ...

    Authors: Shaobo Mo, Zheng Zhou, Yaqi Li, Xiang Hu, Xiaoji Ma, Long Zhang, Sanjun Cai and Junjie Peng
    Citation: Cancer Cell International 2020 20:285
  21. Evidence suggests that altered DNA methylation plays a causative role in the occurrence, progression and prognosis of gastric cancer (GC). Thus, methylated-differentially expressed genes (MDEGs) could potentia...

    Authors: Yang Li, Rongrong Sun, Youwei Zhang, Yuan Yuan and Yufeng Miao
    Citation: Cancer Cell International 2020 20:284
  22. Prostate cancer (PCa) greatly threatens men’s lives, with high incidence and mortality. Recently, the research of long non-coding RNAs (lncRNAs) has made breakthroughs in the development of human cancers. This...

    Authors: Huijuan Wu, Xin Tian and Chaoyang Zhu
    Citation: Cancer Cell International 2020 20:283
  23. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Wanqing Weng, Zhongjing Zhang, Weiguo Huang, Xiangxiang Xu, Boda Wu, Tingbo Ye, Yunfeng Shan, Keqing Shi and Zhuo Lin
    Citation: Cancer Cell International 2020 20:282

    The original article was published in Cancer Cell International 2020 20:231

  24. Metastasis is a major cause of failed colorectal cancer (CRC) treatment. While lung metastasis (LM) is observed in 10–15% of patients with CRC, the genetic mechanisms that cause CRC to metastasize to the lung ...

    Authors: Nan Zhang, Jiabo Di, Zaozao Wang, Pin Gao, Beihai Jiang and Xiangqian Su
    Citation: Cancer Cell International 2020 20:281
  25. Aberrant activity of cell cycle proteins is one of the key somatic events in non-small cell lung cancer (NSCLC) pathogenesis. In most NSCLC cases, the retinoblastoma protein tumor suppressor (RB) becomes inact...

    Authors: Lindsey R. Conroy, Pawel Lorkiewicz, Liqing He, Xinmin Yin, Xiang Zhang, Shesh N. Rai and Brian F. Clem
    Citation: Cancer Cell International 2020 20:280
  26. Alternative splicing (AS) may cause structural and functional variations in the protein to promote the proliferation of tumor cells. However, there is no comprehensive analysis of the clinical significance of ...

    Authors: Chuan Liu, Chuan Hu, Zhi Li, Jing Feng, Jiale Huang, Bowen Yang and Ti Wen
    Citation: Cancer Cell International 2020 20:279
  27. Oncolytic viruses have emerged as an alternative therapeutic modality for cancer as they can replicate specifically in tumour cells and induce toxic effects leading to apoptosis. Despite the great potentials a...

    Authors: Syed Umar Faruq Syed Najmuddin, Zahiah Mohamed Amin, Sheau Wei Tan, Swee Keong Yeap, Jeevanathan Kalyanasundram, Muhamad Alhapis Che Ani, Abhimanyu Veerakumarasivam, Soon Choy Chan, Suet Lin Chia, Khatijah Yusoff and Noorjahan Banu Alitheen
    Citation: Cancer Cell International 2020 20:278
  28. There have been attempts to develop novel anti-tumor drugs in cancer therapy. Although satisfying results have been observed at a consequence of application of chemotherapeutic agents, the cancer cells are cap...

    Authors: Milad Ashrafizadeh, Masoud Najafi, Reza Mohammadinejad, Tahereh Farkhondeh and Saeed Samarghandian
    Citation: Cancer Cell International 2020 20:277
  29. As bladder cancer was recognized to be immunogenic, dozens of studies have focused on immune biology of BLCA, but little is known about its relationship with the long non-coding RNAs (lncRNAs).

    Authors: Rui Cao, Lushun Yuan, Bo Ma, Gang Wang and Ye Tian
    Citation: Cancer Cell International 2020 20:276
  30. Radioresistance is an obstacle to limit efficacy of radiotherapy. Meanwhile, long non-coding RNAs (lncRNAs) have been reported to affect radioresistance. Here, we aimed to investigate lncRNAs involving radiore...

    Authors: Yufeng Jiang, Wei Li, Yang Yan, Xudong Yao, Wenyu Gu and Haimin Zhang
    Citation: Cancer Cell International 2020 20:274
  31. Long non-coding RNAs (LncRNAs) are a class of newly identified transcripts recognized as critical governors of gene expression during human carcinogenesis, whereas their tumor-suppressive or tumor-promoting ef...

    Authors: Xiongdong Zhong, Xianchang Yu, Xiaoyan Wen, Lei Chen and Ni Gu
    Citation: Cancer Cell International 2020 20:272
  32. Aberrant activation of β-catenin has been shown to play important roles in the chemoresistance of acute lymphoblastic leukemia (ALL), but the involvement and mechanism of β-catenin in methotrexate (MTX) resist...

    Authors: Shu-Guang Liu, Zhi-Xia Yue, Zhi-Gang Li, Rui-Dong Zhang, Hu-Yong Zheng, Xiao-Xi Zhao and Chao Gao
    Citation: Cancer Cell International 2020 20:271
  33. Ovarian cancer (OvCa) is one of the most fatal cancers among females in the world. With growing numbers of individuals diagnosed with OvCa ending in deaths, it is urgent to further explore the potential mechan...

    Authors: Jingxuan Chen, Yun Cai, Rui Xu, Jiadong Pan, Jie Zhou and Jie Mei
    Citation: Cancer Cell International 2020 20:270
  34. Cancer stem cell (CSC) is identified in osteosarcoma (OS) and considered resistant to chemotherapeutic agents. However, the mechanism of osteosarcoma stem cell (OSC) resistant to chemotherapy remains debatable...

    Authors: Feng Wang, Zhiyu Zhang, Qin Li, Tao Yu and Chengbin Ma
    Citation: Cancer Cell International 2020 20:269
  35. Endometrial carcinoma (EC) is one of the most common malignant tumors in gynecology. The potential functions and mechanisms of long noncoding RNAs (lncRNAs) in the occurrence and progression of EC remains uncl...

    Authors: Lingling Gao, Xin Nie, Wenchao Zhang, Rui Gou, Yuexin Hu, Yue Qi, Xiao Li, Qing Liu, Juanjuan Liu and Bei Lin
    Citation: Cancer Cell International 2020 20:268
  36. The effect of lncRNA FTX on non-alcoholic fatty liver disease (NAFLD) conversion to hepatocellular carcinoma (HCC) is unclear.

    Authors: Huajun Wu, Zhiwei Zhong, Anji Wang, Chunhui Yuan, Ke Ning, Huanhuan Hu, Chao Wang and Xiangbao Yin
    Citation: Cancer Cell International 2020 20:266
  37. Circular RNA (circRNA) is a novel class of regulatory noncoding RNA (ncRNA) molecules with a unique covalently closed loop structure. Next-generation sequencing shows that thousands of circRNAs are widely and ...

    Authors: Xuejing Yang, Jie Mei, Huiyu Wang, Dingyi Gu, Junli Ding and Chaoying Liu
    Citation: Cancer Cell International 2020 20:265
  38. Stomach adenocarcinoma (STAD) is the fifth most prevalent cancer in the world and ranks third among cancer-related deaths worldwide. The tumour microenvironment (TME) plays an important role in tumorigenesis, ...

    Authors: Lin Zhou, Wei Huang, He-Fen Yu, Ya-Juan Feng and Xu Teng
    Citation: Cancer Cell International 2020 20:264
  39. The transmembrane glycoprotein podoplanin (PDPN) is upregulated in some tumors and has gained attention as a malignant tumor biomarker. PDPN molecules have platelet aggregation-stimulating domains and, are the...

    Authors: Nobuo Watanabe, Masako Kidokoro, Makiko Tanaka, Shigeaki Inoue, Tomoatsu Tsuji, Hisako Akatuska, Chisa Okada, Yumi Iida, Yoshinori Okada, Yusuke Suzuki, Takehito Sato, Takashi Yahata, Noriaki Hirayama, Yoshihide Nakagawa and Sadaki Inokuchi
    Citation: Cancer Cell International 2020 20:263
  40. Multiple Myeloma (MM) is a hematologic malignant disease whose underlying molecular mechanism has not yet fully understood. Generally, cell adhesion plays an important role in MM progression. In our work, we i...

    Authors: Yue Peng, Dong Wu, Fangmei Li, Peihua Zhang, Yuandong Feng and Aili He
    Citation: Cancer Cell International 2020 20:262
  41. Circular RNA downstream neighbor of SON (circDONSON) has been revealed to promote gastric cancer (GC) growth and invasion, while the role and molecular mechanism underlying circDONSON in GC cisplatin (DDP) res...

    Authors: Yong Liu, Jianzhong Xu, Min Jiang, Lingna Ni and Yang Ling
    Citation: Cancer Cell International 2020 20:261
  42. Recent studies have demonstrated that the kallikrein and kallikrein-related peptidases (KLKs) exhibit aberrant expression in patients with colorectal cancer (CRC) and might be considered as potential prognosti...

    Authors: Qiliang Peng, Yi Shen, Peifeng Zhao, Ming Cheng, Yongyou Wu and Yaqun Zhu
    Citation: Cancer Cell International 2020 20:260
  43. Osteosarcoma (OS) is a common malignant bone tumor originating in the interstitial tissues and occurring mostly in adolescents and young adults. Energy metabolism is a prerequisite for cancer cell growth, prol...

    Authors: Naiqiang Zhu, Jingyi Hou, Guiyun Ma, Shuai Guo, Chengliang Zhao and Bin Chen
    Citation: Cancer Cell International 2020 20:259
  44. Cisplatin is widely used as a first-line treatment for non-small cell lung cancer (NSCLC), but chemoresistance remains a major clinical obstacle for efficient use. As a microRNA, miR-223 was reported to promot...

    Authors: Hui Wang, Jiabin Chen, Shufen Zhang, Xiaoxiao Zheng, Shangzhi Xie, Jiayan Mao, Ying Cai, Xuemei Lu, Liqiang Hu, Jian Shen, Kequn Chai and Wei Chen
    Citation: Cancer Cell International 2020 20:258

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.6 - 5-year Impact Factor
    0.994 - SNIP (Source Normalized Impact per Paper)
    1.145 - SJR (SCImago Journal Rank)

    2023 Speed
    34 days submission to first editorial decision for all manuscripts (Median)
    110 days submission to accept (Median)

    2023 Usage 
    2,067,719 downloads
    1,052 Altmetric mentions 

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here